Based on patents licensed from academic laboratories or arising from its own R&D results, Ipsogen focuses on the development, manufacturing and marketing of diagnostic tests.

These steps are directly managed by the group save for sales in a few countries where they are delegated to distributors because of the complexity of targeted markets.

Ipsogen has established a production site compliant with the requirements of Good Manufacturing Practice (GMP) and certified ISO 13485:2003 in 2007.

Ipsogen sells its products in 50 countries to 200 reference centers for cancer therapy, 20 private laboratories and numerous distributors.

The Group has a commercial office in Europe and an equivalent structure in the United States; each department is responsible for sales, product support and marketing. The sales force is deployed locally in 5 worldwide zones:

• the United States, where the Group has been having a commercial subsidiary in New Haven, Connecticut, since 2005,
  
  
• the French-speaking European countries,
  
  
• Spain and Portugal,
  
  
• Germany and the Netherlands,
  
  
• UK and Scandinavian countries.